A Study of the Safety and Effectiveness of Liquid Certolizumab Pegol in the Treatment of Signs and Symptoms of Rheumatoid Arthritis and in Prevention of Joint Damage in Patients With Active Rheumatoid Arthritis
Clinical trial NCT00160641 · COMPLETED
Trial details
- NCT number
- NCT00160641
- Sponsor
- UCB Pharma
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-11-01
- Primary completion
- 2012-02-01
- Enrollment
- 567
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.